IXC
INVEX THER FPO [IXC]
Healthcare · ASX Small Cap
$0.1150 +0.0%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when IXC triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Trading above both moving averages — the trend is your friend here
- Volume surging at 21.3x normal while price falls — heavy selling pressure
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (36 quarters)
- 4C filed 2026-07-23
- Very high P/S ratio (184.6x)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (2.56%/day)
- Altman Z-Score grey zone (2.98, low-confidence approx)
- Liquidity risk: 8 zero-volume days in last 20
- RBA hiking (-3pts)
Risk Signals
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
Expected next for IXC
Window: 11 Oct to 6 Nov
The last 10 moved IXC -2.8% on the day, on average — an observation, not a guide to what happens next.
Window: 25 Sep to 24 Nov
The last 10 moved IXC -2.8% on the day, on average — an observation, not a guide to what happens next.
Window: 15 Oct to 10 Nov
The last 10 moved IXC -2.8% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE Appendix 4G and Corporate Governance Statement
LOW Appendix 4E and Annual Report to shareholders
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-08-31 | Appendix 4G and Corporate Governance Statement |
| 2026-08-31 | Appendix 4E and Annual Report to shareholders PRICE SENSITIVE |
| 2026-07-23 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$8.6M
Market Cap
43K
Avg Volume
21.3x
Vol Ratio
$0.09 — $0.18
52-Week Range
N/A
Short Interest
20 qtrs
Cash Runway
-29.5%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 61% |
| L | Leader vs Laggard | laggard | RS: -7 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track IXC and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required